Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide.

被引：0
|
作者：
Jónsdóttir, Thórunn [1 ]
Gunnarsson, Iva [1 ]
Risselada, Anke [1 ]
Wallerskog, Therese [1 ]
Winqvist, Ola [1 ]
Wikström, Ann-Charlotte [1 ]
Klareskog, Lars [1 ]
van Vollenhoven, Ronald F. [1 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S259 / S260
页数：2
相关论文
共 50 条
  • [1] Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide
    Jonsdottir, Porunn
    Gunnarsson, Iva
    Risselada, Anke
    Wallerskog, Therese
    Welin-Henriksson, Elisabeth
    Winqvist, Ola
    Wikstrom, Charlotte
    Klareskog, Lars
    van Vollenhoven, Ronald F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 26 - 27
  • [2] Fertility in male SLE patients treated with cyclophosphamide.
    Rosenkranz, ME
    Harbison, M
    Lehman, TJA
    Onel, KB
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S316 - S316
  • [3] Treatment of resistant SLE with rituximab administered without cyclophosphamide.
    Ryan, JP
    Singer, NG
    Scalzi, LV
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S413 - S414
  • [4] Rituximab plus cyclophosphamide in severe SLE
    Jonsdottir, T.
    Gunnarsson, I.
    Risselada, A. R.
    Klareskog, L.
    Van Vollenhoven, R. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 200 - 200
  • [5] Treatment of refractory SLE with rituximab plus cyclophosphamide:: clinical effects, serological changes, and predictors of response
    Jonsdottir, T.
    Gunnarsson, I.
    Risselada, A.
    Henriksson, E. W.
    Klareskog, L.
    van Vollenhoven, R. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 330 - 334
  • [6] Serological changes in patients with SLE following treatment with rituximab plus cyclophospehamide
    Jonsdottir, T.
    Wallerskog, T.
    Risselada, A. P.
    Winqvist, O.
    Wikstrom, A. C.
    Gunnarsson, I.
    Malmstrom, V.
    Trollmo, C.
    Klareskog, L.
    Van Vollenhoven, R. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 362 - 362
  • [7] Immunoglobulin Concentrations and Infection Risk Among Patients with ANCA-Associated Vasculitis Treated with Rituximab or Cyclophosphamide.
    Specks, Ulrich
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert F.
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Tole, Swati
    Brunetta, Paul
    Shen, Shuyi
    Tchao, Nadia
    Fessler, Barri J.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Phippard, Deborah J.
    Asare, Adam
    Lim, Noha
    Ikle, David
    Jepson, Brett
    Lail, Alice
    Mueller, Mark
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S310 - S311
  • [8] Histopathological and clinical changes in patients with severe lupus nephritis treated with rituximab plus cyclophosphamide: A rebiopsy study in 7 patients
    Gunnarsson, I.
    Sundelin, B.
    Jonsdottir, T.
    Jacobsson, S. H.
    Welin-Henriksson, E.
    Van Vollenhoven, R. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 64 - 64
  • [9] Rituximab plus cyclophosphamide in severe SLE: Results in 15 patients who failed conventional immunosuppressive therapy
    van Vollenhoven, RF
    Gunnarsson, I
    Welin-Henriksson, E
    Jonsdottir, T
    Sundelin, B
    Jacobsson, S
    Klareskog, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S741 - S741
  • [10] Impact on bone mineral density of the treatment with gonadotropin-releasing hormone antagonists (gnrh-a) in SLE patients treated with IV cyclophosphamide.
    Pampin, Eva Perez
    Varela, Antonio Mera
    Pan, Francisco J. Maceiras
    Gomez-Reino, Juan J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S431 - S432
12345